BLS vs MYX

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

BLS MYX
Technical
49
53
Catalyst
55
50
Sentiment
50
50
Fundamental
96
85
Momentum
84
38
Risk Gate
50
42

Key Metrics

BLS Metric MYX
$193.2MMarket Cap$225.9M
218KAvg Volume (20d)212K
+0.0%Short Interest+2.4%
$1.10052-Week High$6.500
$0.33052-Week Low$2.040
+1.8%Daily Change+0.7%
$0.855Reference Price$2.770
+66.1%ROE-20.6%
+18.7%Profit Margin-20.4%

Active Signals

BLS Signals

●MACD momentum is losing steam
●Drifting lower — down 8.1% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.0x)
●Strong revenue growth (+150%)
●Piotroski F-Score strong (8/9, low-confidence approx)

MYX Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Drifting lower — down 5.1% over the last 5 days
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)

Ask Scout AI to compare BLS and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs NSB →BLS vs NXN →BLS vs OCC →BLS vs PAR →BLS vs PCK →
BLS Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).